Tokyo, Aug. 8 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058727) titled 'Longitudinal associations between serum orexin A levels and physical activity, sleep, and clinical indicators in patients with schizophrenia: an exploratory study' on Aug. 7.
Study Type:
Observational
Primary Sponsor:
Institute - Kurita hospital
Condition:
Condition - Schizophrenia
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - This study aims to explore the longitudinal associations between serum orexin-A levels and physical activity, sleep, and clinical symptoms in patients with chronic schizophrenia, in order to investigate the potential pathophysiological role of orexin-A.
Basic objectives2 - Others
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - 65
years-old
>
Gender - Male and Female
Key inclusion criteria - 1.Diagnosis of schizophrenia according to DSM-5 criteria
2.Continuous hospitalization for more than one year at Kurita Hospital
3.Age under 65 years at the time of the study
Key exclusion criteria - 1.Participants whose actigraph wearing rate was less than 80%
2.Deemed unsuitable for participation by the attending psychiatrist or principal investigator
Target Size - 17
Recruitment Status:
Recruitment status - No longer recruiting
Date of protocol fixation - 2025 Year 07 Month 20 Day
Date of IRB - 2025 Year 07 Month 25 Day
Anticipated trial start date - 2025 Year 07 Month 25 Day
Last follow-up date - 2025 Year 10 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067061
Disclaimer: Curated by HT Syndication.
